Seshadri Neervannan insider trades

Open-market stock purchases and sales by Seshadri Neervannan, Chief Operating Officer at Tarsus Pharmaceuticals, Inc, from SEC Form 4 filings since Jan 7, 2021.

Recent trades

DateStockTradeValue
Sep 4, 2026TARS Tarsus Pharmaceuticals, IncSold$388K
Mar 20, 2026TARS Tarsus Pharmaceuticals, IncSold$200K
Mar 19, 2026TARS Tarsus Pharmaceuticals, IncSold$307K
Mar 18, 2026TARS Tarsus Pharmaceuticals, IncSold$248K
Mar 17, 2026TARS Tarsus Pharmaceuticals, IncSold$217K
Mar 15, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 15, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 15, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 15, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 15, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 5, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 5, 2026TARS Tarsus Pharmaceuticals, IncBought (not open market)—
Mar 4, 2026TARS Tarsus Pharmaceuticals, IncSold$641K
Dec 16, 2025TARS Tarsus Pharmaceuticals, IncSold (not open market)—
Dec 16, 2025TARS Tarsus Pharmaceuticals, IncBought (not open market)—

Companies traded

  • TARS Tarsus Pharmaceuticals, Inc: 16 sales, last Sep 4, 2026

Get free alerts when Seshadri Neervannan files a new trade →